LRPPRC expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.556200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.305200E-01
Normal-vs-Stage2
9.234600E-01
Normal-vs-Stage3
1.143040E-01
Normal-vs-Stage4
3.016800E-01
Stage1-vs-Stage2
9.671400E-01
Stage1-vs-Stage3
5.055600E-02
Stage1-vs-Stage4
2.081400E-01
Stage2-vs-Stage3
7.300000E-02
Stage2-vs-Stage4
2.254800E-01
Stage3-vs-Stage4
2.576000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.550000E-01
Normal-vs-AfricanAmerican
5.046800E-01
Normal-vs-Asian
7.346600E-01
Caucasian-vs-AfricanAmerican
4.158200E-01
Caucasian-vs-Asian
5.390800E-01
AfricanAmerican-vs-Asian
1.809180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.525400E-01
Normal-vs-Female
9.496200E-01
Male-vs-Female
9.782600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.031000E-01
Normal-vs-Age(41-60Yrs)
6.591200E-01
Normal-vs-Age(61-80Yrs)
8.490000E-01
Normal-vs-Age(81-100Yrs)
6.785000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.809800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.147200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.582600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.248300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.816800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.601020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.990000E-01
Normal-vs-Daily Drinker
9.175200E-01
Normal-vs-Weekly Drinker
6.032800E-01
Normal-vs-Occasional Drinker
5.112800E-01
Normal-vs-Social Drinker
7.113200E-01
Non Drinker-vs-Daily Drinker
9.721400E-01
Non Drinker-vs-Weekly Drinker
5.445400E-01
Non Drinker-vs-Occasional Drinker
1.802250E-01
Non Drinker-vs-Social Drinker
3.623200E-01
Daily Drinker-vs-Weekly Drinker
5.535800E-01
Daily Drinker-vs-Occasional Drinker
2.563400E-01
Daily Drinker-vs-Social Drinker
4.175600E-01
Weekly Drinker-vs-Occasional Drinker
5.003800E-02
Weekly Drinker-vs-Social Drinker
1.550420E-01
Occasional Drinker-vs-Social Drinker
9.170800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.842100E-02
Normal-vs-Grade 2
1.902390E-02
Normal-vs-Grade 3
2.182400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.245900E-02
Grade 1-vs-Grade 3
3.302800E-03
Grade 1-vs-Grade 4
5.842100E-02
Grade 2-vs-Grade 3
3.685600E-02
Grade 2-vs-Grade 4
1.902390E-02
Grade 3-vs-Grade 4
2.182400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.318200E-01
Normal-vs-NonDiabetic
9.756400E-01
Diabetic-vs-NonDiabetic
4.294000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.699000E-01
Normal-vs-NoPancreatitis
9.843000E-01
Pancreatitis-vs-NoPancreatitis
9.706600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.882600E-01
Normal-vs-N1
9.450000E-01
N0-vs-N1
8.387200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.593600E-01
Normal-vs-TP53-NonMutant
8.176400E-01
TP53-Mutant-vs-TP53-NonMutant
7.902600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
